MedX Health Corp (MDX.V)

0.2100 -0.0200 (-8.70%) At close: 3:59PM EST

MedX Health Corp

1495 Bonhill Road
Unit #1
Mississauga, ON L5T 1M2
Canada
905 670 4428
http://www.medxhealth.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert von der Porten B.A., M.B.A., MBA, BA	Chairman, Interim CEO & Pres	112.5k	N/A	N/A
Mr. James H. Cooke	Chief Financial Officer	158.5k	N/A	N/A
Mr. Louie Canitano	COO & MD of Light Therapy Products	147.5k	N/A	N/A
Mr. Peter Holmes B.A., M.A	VP of Sales	N/A	N/A	1968
Dr. Daniel A. Kaute	Managing Director of Europe	N/A	N/A	N/A
Mr. Scott Naughton	Managing Director of US Operations	N/A	N/A	N/A
Mr. Mike Druhan	Pres of Dermatological Services & Products	N/A	N/A	N/A
Mr. Naman Demaghlatrous	Managing Director of EMEA	N/A	N/A	N/A
Mr. Christopher H. Freeman	Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, Australia, Asia, and Latin America. The company offers SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. Its product portfolio includes SIMSYS, a skin analysis system; MoleMate, a non-invasive screening device that is designed for general practitioners and skin specialists; and SIAMETRICS, a skin visualization and measurement technology that allows cosmetic formulators and active ingredient manufacturers to measure and quantify the concentrations of melanin, haemoglobin, and collagen in living human skin. The company also provides rehab laser console systems, dental laser console systems, OraLase portable laser probes, MedX home treatment systems, and rehab portable lasers. In addition, it operates DermSecure telemedicine platform that enables the Web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Corporate Governance

MedX Health Corp’s ISS Governance QualityScore as of December 3, 2020 is 4. The pillar scores are Audit: 7; Board: 3; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.